Nuvectis Pharma, Inc.

Nuvectis Pharma (NVCT) shows no cyber incidents or major red-flag 8-K filings in the past 90 days, though absence of recent events does not indicate absence of risk. Our short observation window captures limited signal; the full SEC analysis extends coverage to 12 months of filings, maps dilution trajectories, and flags financing history and AI-detected risk patterns. The full $49 Report adds quantified dilution risk scores, 8-K context and timing analysis, and forward-looking capital structure signals that may not yet be visible in raw filings.